Feedback
Settings

Settings

Goto Application

1. US20120121607 - Antibodies to Clostridium difficile toxins

PermaLink
Office
United States of America
Application Number 13202557
Application Date 19.02.2010
Publication Number 20120121607
Publication Date 17.05.2012
Grant Number 08709428
Grant Date 29.04.2014
Publication Kind B2
IPC
A61K 39/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
40bacterial
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07K 16/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
12against material from bacteria
CPC
C07K 16/1282
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12against material from bacteria
1267from Gram-positive bacteria
1282from Clostridium (G)
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
C07K 2317/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
20characterized by taxonomic origin
Applicants Shone Clifford
Health Protection Agency
Landon John
Micropharm Limited
Inventors Shone Clifford
Landon John
Agents Evan Law Group LLC
Priority Data 0902851.5 20.02.2009 GB
0916153.0 15.09.2009 GB
Title
(EN) Antibodies to Clostridium difficile toxins
front page image
Abstract
(EN)

The present invention provides an antibody composition comprising ovine antibodies, for use in the prevention or treatment of C. difficile infection wherein the antibodies bind to a C. difficile toxin.
Related patent documents
EP2405940
CN102365097
CA2752815
AU2010215275
WO/2010/094970
JP2012518624
IN5618/DELNP/2011
US20150010580
# -